Heartflow (NASDAQ:HTFL) Releases Earnings Results, Misses Expectations By $1.26 EPS

Key Points

• Heartflow reported a quarterly earnings loss of ($1.46) per share, significantly missing the consensus estimate of ($0.20) by ($1.26).
• Following the earnings announcement, shares of Heartflow (HTFL) increased by 1.2%, closing at $32.88, with a trading volume of 1,486,218 shares.
• Multiple analysts have initiated coverage on Heartflow, with average price targets ranging from $35.00 to $38.00 and a consensus rating of "Moderate Buy."

Heartflow (NASDAQ:HTFL - Get Free Report) issued its quarterly earnings data on Friday. The company reported ($1.46) earnings per share for the quarter, missing analysts' consensus estimates of ($0.20) by ($1.26), Zacks reports. The firm had revenue of $43.42 million during the quarter, compared to analysts' expectations of $43.20 million.

Heartflow Stock Performance

HTFL stock traded up $0.40 during midday trading on Friday, reaching $32.88. 1,486,218 shares of the company traded hands, compared to its average volume of 321,644. Heartflow has a 52-week low of $26.56 and a 52-week high of $36.68.

Analysts Set New Price Targets

A number of research analysts have recently commented on HTFL shares. Piper Sandler started coverage on Heartflow in a research note on Tuesday, September 2nd. They issued an "overweight" rating and a $38.00 target price for the company. Stifel Nicolaus began coverage on Heartflow in a research note on Tuesday, September 2nd. They set a "buy" rating and a $35.00 price objective for the company. Morgan Stanley began coverage on Heartflow in a research note on Tuesday, September 2nd. They set an "equal weight" rating and a $35.00 price objective for the company. Zacks Research upgraded Heartflow to a "hold" rating in a research note on Wednesday, September 3rd. Finally, Wall Street Zen upgraded Heartflow to a "hold" rating in a research note on Saturday, August 16th. Four research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $35.80.

Heartflow Company Profile

We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.